Global Cbd Oil Market Bwc20146

Global Cbd Oil Market Bwc20146

SPECIAL OFFER : 25% Super Discount For All !

Global CBD Oil Market, By Source Type (Hemp, Marijuana), By Distribution Channel (B2B, B2C), By End-Use (Medical Treatment, Pharmaceuticals); Trend Analysis, Market Competition Scenario & Outlook, 2016-2026

  • Published Date: September 2020
  • Report ID: BWC20146
  • Available Format: PDF
  • Page: 173

Report Overview

Global CBD Oil Market size- Industry Trends & Outlook Report 2026

The Global CBD Oil Market size is expected to reach USD 28.67 billion by 2026 from USD 3.87 billion in 2019, at a CAGR of 33.12% during the projection period 2020-26. The increasing recognition of healing properties and health benefits of CBD oil drives the CBD oil market. Besides, growing acceptance and approvals from the states offer promising market prospects for CBD oil-infused medicines or food items, or cosmetic products. Marketing initiatives by industry players and social media influencers have turned the wave in favor of CBD oil consumption. Subsequently, the product range containing CBD oil is expanding to include skincare, intimate lubricants, hair-care, gummies, pills, and infused beverages besides pharmaceuticals and cosmetics. However, the complexity of regulations by major countries across the globe and high costs associated with its manufacture and trade retards market growth.

Global CBD Oil Market Overview

CBD Oil is extracted from hemp or marijuana found in the Cannabis Sativa plant. The moderate CBD oil consumption does not cause psychoactive effects but helps mitigate anxiety & depression, cancer symptoms, diabetic conditions, and reduce acne. CBD oil was a controlled substance earlier, and its trade, exchange, or manufacture was subject to many regulations in the US and other countries. However, over the last few years, CBD oil has received acceptance due to its safe consumption and several health benefits. It finds traction in various industrial applications such as food & beverages, personal care & cosmetics, and pharmaceuticals. The health and wellness retailers are increasingly allotting shelf space for CBD oil products due to its recognized health benefits and higher profit margins.

Global CBD Oil Market Outlook and Trends

Growth drivers 

Increasing State Approvals for Legitimate Use

As many as 33 states of the US have legalized the use of CBD oil for medical usage, and ten states have allowed its recreational use. Other countries such as Uruguay, Canada, and some others have legalized the use of marijuana. CBD oil is increasingly available and is consumed in the form of tinctures, infused edibles, topical and more by the consumers for treatment and recreational purposes. More and more government approved pharmacies, dispensaries and stores are stocking CBD oil-based products, including concentrates, lotions, oils, capsules, and edibles such as baked goods, gums, candies, coffee, chocolates, etc., driving the growth of the market.

Rising Awareness about Its Health Benefits

Multiple medical studies have shown that high efficacy of medicinal CBD oil derived from marijuana in various conditions of cancer, diabetes, acne, depression, and anxiety. CBD oil is beneficial for skin also because of its anti-inflammatory, anti-aging, and antioxidant properties. Due to increasing awareness about medicinal benefits and its properties, people are adopting CBD oil in various applications over the world, triggering its more demand.


Complexity of Guidelines & Regulations

Though CBD oil has been recognized for its various benefits, its consumption is still regulated and suspected, which impacts the market growth. Companies engaged in the production or trade of CBD oil need to comply with multiple tedious regulatory guidelines, discouraging market players. Medical practitioners also need to follow ambiguous guidelines in prescribing CBD oil-based medications. However, research and innovative product delivery solutions with quality cannabis plant harvests may help overcome this challenge.

Impact of COVID-19 in industry

The economies over the world have reported shrinkage in production, trade, and distribution activities due to restrictions on transport and production. CBD oil operations have also been affected due to supply chain and distribution constraints besides disruptions in production. However, as CBD oil offers healthcare benefits in various conditions and the variations offered by market players are likely to propel the market growth.

Market Segmentation

CBD Oil market is segmented on Source Type, Distribution Channel, and By End-user. Based on Source Type, the market is divided into Hemp and Marijuana segments. The marijuana segment fetched the largest revenue share in 2019 and, is expected to register the highest growth during the projection period due to its high adoption combined with its growing legalization. Marijuana-derived products include oils, tinctures, concentrates, and other topical solutions, which are increasingly recommended for wellness and medical purposes. In contrast, Hemp-derived marijuana finds its traction in nutraceuticals, pharmaceuticals, personal care & cosmetics, and food & beverages. The hemp segment is also anticipated to receive a boost due to its increasing demand from numerous skincare and cosmetic brands.


CBD Oil Market distribution network consists of B2C and B2B segments wherein the B2C segment includes online pharmacies, retail, and hospital pharmacies while B2B includes wholesalers and distributors. In this market, the B2C segment dominates with its most immense contribution in revenues and, is expected to retain the same due to the higher adoption of CBD oil-infused medicines in hospital pharmacies.

Based on End-use, the market is divided into Medical Treatment and Pharmaceutical segments. The medical segment dominates the market with significant share and, is anticipated to maintain the same share due to its rising use in epilepsy, sleep disorders, chronic pain, anxiety, and symptoms of multiple sclerosis. The pharmaceutical segment is expected to witness the highest growth during the projection period because of its use in manufacturing CBD infused drugs or products for treating various conditions. For instance, GW Pharmaceuticals, Isodiol International Inc., and CannaHealth manufacture soft-gel capsules and tinctures using CBD oil for treating epilepsy and multiple sclerosis symptoms.

Regional Insights

North America retained the significant market share in the year 2019 and, will continue the same in the forthcoming period because of increasing approvals for its use in Canada and the US as well as its wide acceptance in healthcare. Besides, the Farm bill in the US also supports the production of hemp-derived CBD oil. The Asia-Pacific market is also expected to notice substantial growth due to the establishments of a hemp manufacturing plant in China. China accounts for the significant production and exports of hemp-based CBD in the region, and growing legalization and usage of CBD oil is expected to fuel the demand further in these countries.

Competitive landscape


The major players in the market are Isodiol International Inc., ENDOCA, Medical Marijuana Inc., Cannoid LLC, NuLeaf Naturals LLC, Pharmahemp d.o.o. , Canopy Growth Corporation, Elixinol, Folium Biosciences, Aurora Cannabis, and others.

Recent Developments

May 21, 2020: New report of Medical Marijuana shows that CBD usage rates are on the rise in the US. 86% of US citizens know about CBD, and 20% of them have used it at least once. It also reveals that CBD oil consumption supports balance and optimizes the functioning of the human body.

October 9, 2019: Isodiol International Inc announces its strategic relationship with Vitamin Shoppe, Inc. for the launch of the company’s Iso-Sport hemp-extracted Products.

Scope of the Report



Years Considered

Historical data – 2016-2018

Base Year – 2019

Forecast – 2020 – 2026

Facts Covered

Revenue in USD Billion

Market Coverage

U.S, Canada, Germany, UK, France, Italy, Spain, Brazil, Mexico, Japan, South Korea, China, India, South Korea UAE, South Africa, Saudi Arabia.

Product/Service Segmentation

By Source Type, By Distribution Channel, By End-use and By Region

Key Players

Isodiol International Inc., ENDOCA, Medical Marijuana Inc., Cannoid LLC, NuLeaf Naturals LLC, Pharmahemp d.o.o., Canopy Growth Corporation, Elixinol, Folium Biosciences, Aurora Cannabis and others.

By Source Type

Ø  Hemp

Ø  Marijuana

By Distribution Channel

Ø  B2C

Ø  B2B

By End-use

Ø  Medical Treatment

Ø  Pharmaceuticals

By Region 

Ø  North America

Ø  Europe

Ø  Asia Pacific

Ø  Latin America

Ø  Middle East & Africa


The objective of the Study:


Ø  To analyze and estimate the Global CBD Oil Market size, in terms of value.

Ø  To examine the market segmentation carefully and estimate the market size, in terms of value, based on the region by segmenting the Global CBD Oil Market into five regions, namely, North America, Europe, Asia Pacific, Rest of the World and their leading countries.

Ø  To outline, categorize, and project the Global CBD Oil Market based on the Source, End-user, Distribution Channel, and Region.

Ø  To examine competitive developments in product form, source, and industry end-users within the Global CBD Oil Market.

Ø  To highlight market dynamics such as drivers, restraints, opportunities, and challenges and their impact.

Ø  To provide a detailed competitive landscape, including major players, their strategic profiles, and market shares.


Business Questions Answered by the Report


Ø  How will the market drivers, restraints, and opportunities affect the market dynamics?

Ø  What will be the market size in terms of value and volume and market statistics with a detailed classification?

Ø  Which segment dominates the market or region, and which one will be the fastest-growing, and why?

Ø  Who are the key players in the market, and what is their share?

Ø  What is the strategy adopted by key players, and how does it affect the existing and new players?


Customization Scope for the Client


Client satisfaction is our first and last priority, and that is why BlueWeave Consulting offers customization as per the client’s specific needs. The following customization options are available for the report:

Ø  Additional Company Information

Ø  Detail Analysis of five additional companies

Ø  Additional country analysis

Ø  Detailed segment analysis 

1.    Research Framework

1.1. Research Objective

1.2. Product Overview

1.3. Market Segmentation

2.    Research Methodology

2.1. Qualitative Research

2.1.1.       Primary & Secondary Sources

2.2. Quantitative Research

2.2.1.       Primary & Secondary Sources

2.3. Breakdown of Primary Research Respondents, By Region

2.3.1.       Secondary Research

2.3.2.       Primary Research

2.4. Breakdown of Primary Research Respondents

2.5. Market Size Estimation

2.6. Assumption For The Study

2.7. Market Breakdown & Data Triangulation

3.    Executive Summary

4.    Global CBD Oil Market Insights

4.1. Industry Value Chain Analysis

4.2. DROC Analysis

4.2.1.       Growth Drivers

4.2.2.       Restraints

4.2.3.       Opportunities

4.2.4.       Challenges

4.3. Technological Landscape

4.4. Regulatory Framework

4.5. Company Market Share Analysis,2019

4.6. Porter’s Five forces analysis

4.6.1.       Bargaining Power of Suppliers

4.6.2.       Bargaining Power of Buyers

4.6.3.       Threat of New Entrants

4.6.4.       Threat of Substitutes

4.6.5.       Intensity of Rivalry

4.7. Strategic Outlook

5.    Global CBD Oil Market Overview

5.1. Market Estimates & Forecast By Value, 2016-2026

5.1.1.       By Value (USD)

5.2. Market Share & Forecast

       5.2.1. By Source Type



                     5.2.2. By Distribution Channel B2C B2B

                     5.2.3. By End-Use

                       Medical Treatment


                     5.2.4. By Region

                        North America


                        Asia Pacific

                        South America

                        Middle East & Africa

6.    North America CBD Oil Market

6.1. Market Estimates & Forecast By Value, 2016-2026

6.1.1.       By Value (USD)

6.2. Market Share & Forecast

6.2.1.       By  Source Type

6.2.2.       By Distribution Channel

6.2.3.       By End Use

6.2.4.       By Country         U.S         Canada

7.    Europe CBD Oil Market

7.1. Market Estimates & Forecast By Value, 2016-2026

7.1.1.       By Value (USD)

7.2. Market Share & Forecast

7.2.1.       By  Source Type

7.2.2.       By Distribution Channel

7.2.3.       By End Use

7.2.4.       By Country         Germany         U.K         France         Italy         Rest of Europe

8.    Asia Pacific CBD Oil Market

8.1. Market Estimates & Forecast By Value, 2016-2026

8.1.1.        By Value (USD)

8.2. Market Share & Forecast

8.2.1.       By  Source Type

8.2.2.       By Distribution Channel

8.2.3.       By End Use

8.2.4.       By Country         China         India         Japan         South Korea         Rest of APAC

9.    South America CBD Oil Market

9.1. Market Estimates & Forecast By Value, 2016-2026

9.1.1.       By Value (USD)

9.2. Market Share & Forecast

9.2.1.       By  Source Type

9.2.2.       By Distribution Channel

9.2.3.       By End Use

9.2.4.       By Country         Brazil         Mexico         Argentina         Rest of Latin America

10.Middle East & Africa CBD Oil Market

10.1.   Market Estimates & Forecast By Value, 2016-2026

10.1.1.    By Value (USD)

10.2.   Market Share & Forecast

10.2.1.    By  Source Type

10.2.2.    By Distribution Channel

10.2.3.    By End Use

10.2.4.    By Country      Saudi Arabia      UAE      South Africa      Rest of MEA

11.Company Profile (Company Overview, Financial Matrix, Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook)*

11.1     Isodiol International Inc.

11.2     ENDOCA

11.3     Medical Marijuana Inc.

11.4     Cannoid LLC

11.5     NuLeaf Naturals LLC

11.6     Pharmahemp d.o.o.

11.7     Canopy Growth Corporation

11.8     Elixinol

11.9     Folium Biosciences

11.10  Aurora Cannabis

11.11  Others

12.Strategic Recommendation

*Financial Details Not Be Captured in Case of Unlisted Companies

**The segmentation and the companies are subjected to modifications based on the in-depth secondary for the final deliverable

Market Segmentation

No data available

By Source Type

Ø  Hemp

Ø  Marijuana

By Distribution Channel

Ø  B2C

Ø  B2B

By End-use

Ø  Medical Treatment

Ø  Pharmaceuticals

By Region 

Ø  North America

Ø  Europe

Ø  Asia Pacific

Ø  Latin America

Ø  Middle East & Africa

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe.